Stratasys, founded in 1989 and headquartered in Eden Prairie, Minnesota, USA, is a global leader in additive manufacturing and 3D printing technology. The company offers a comprehensive range of 3D printers, materials, and software solutions that cater to industries such as aerospace, automotive, healthcare, and consumer products. Stratasys' innovations enable rapid prototyping, manufacturing aids, and end-use part production, facilitating design flexibility and cost efficiency. With a commitment to sustainability and advancing manufacturing processes, Stratasys empowers businesses worldwide to transform their product development and production strategies.
Medical facilities and device manufacturers previously limited by constraints can now create patient-specific models to enhance surgical preparation, elevate patient outcomes, and fast-track innovation.
Stratasys makes several updates with new products and materials that address customer feedback and are designed to unlock more opportunities and functionality for additive manufacturing capabilities.
The companies are collaborating on a landmark research project designed to develop new state-of-the-art solutions for the advancement of medical imaging phantoms for computed tomography (CT) imaging.
The recently introduced J3 DentaJet multi-material 3D printer is already making its mark as a cost-effective entry-level solution to boost productivity and address skilled labour issues among dental labs.
The joint development and commercialization agreement will initially focus on the development of a bioprinting solution for CollPlant’s regenerative breast implants.
Stratasys Ltd., a leader in polymer 3D printing, today introduced TrueDent the first monolithic, full-color 3D printed permanent dentures solution. The TrueDent resin enables labs to create permanent, natural looking gums with accurate tooth structure, shade, and translucency in one continuous print.